ANTHRAX
TODAY'S HEADLINES
FDA approved Fluad, the first seasonal influenza vaccine containing an adjuvant. A trivalent vaccine produced from 3 influenza virus strains (2 subtype A and 1 type B), Fluad is approved for the prevention of seasonal influenza in people aged 65 years and older. Read more |
|
In its latest round of cancer drug approvals, FDA last week approved Portrazza (necitumumab) in combination with 2 forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC). Read more
|
CONTINUING EDUCATION
November 2015
Recognition of drug-induced pulmonary disease and management of idiopathic pulmonary fibrosis
Session code: 15DT36-KXF58
This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.
|
EDITOR'S PICK
A new joint program with the Mount Sinai Health System and Livongo Health, a consumer digital health company, is expected to help diabetics manage their disease better. Details |
|
|
